Clinical trials
Phase 3 trials in Lebanon
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
189 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 2 |
| 2002 | 3 |
| 2003 | 2 |
| 2004 | 6 |
| 2005 | 3 |
| 2006 | 3 |
| 2007 | 4 |
| 2008 | 7 |
| 2009 | 11 |
| 2010 | 7 |
| 2011 | 12 |
| 2012 | 12 |
| 2013 | 9 |
| 2014 | 10 |
| 2015 | 8 |
| 2016 | 8 |
| 2017 | 8 |
| 2018 | 16 |
| 2019 | 17 |
| 2020 | 13 |
| 2021 | 15 |
| 2022 | 4 |
| 2023 | 4 |
| 2024 | 2 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 127 |
| Terminated | 28 |
| Active, not recruiting | 21 |
| Unknown status | 9 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 40 |
| Sanofi | 12 |
| American University of Beirut Medical Center | 11 |
| Hoffmann-La Roche | 9 |
| Pfizer | 9 |
| Novo Nordisk A/S | 8 |
| GlaxoSmithKline | 6 |
| CSL Behring | 5 |
| Shire | 5 |
| Boehringer Ingelheim | 4 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 15 |
| Anemia, Sickle Cell | 13 |
| Carcinoma, Non-Small-Cell Lung | 11 |
| Diabetes Mellitus, Type 2 | 11 |
| Colitis, Ulcerative | 7 |
| Vaso-Occlusive Crises | 7 |
| Multiple Sclerosis | 6 |
| Neoplasm Metastasis | 6 |
| Anemia | 5 |
| Hematologic Diseases | 5 |
Trials
Showing 1 to 25 of 189. Each trial links to its page on Pharma Observatory.
89 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.